TrialJournal of neurosurgery2022

Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.

Yuzaburo Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.